Another early winner picked by TEDCO’s Maryland Investment Initiative, this JHU-spinout continues to focus on its mission to treat vision loss
Source: External source
Baltimore biopharmaceutical company AsclepiX Therapeutics Inc. is developing therapies to target eye diseases.
Posted November 13, 2018
About TEDCO
TEDCO, the Maryland Technology Development Corporation, enhances economic empowerment growth through the fostering of an inclusive entrepreneurial innovation ecosystem. TEDCO identifies, invests in, and helps grow technology and life science-based companies in Maryland. Learn more at www.tedcomd.com.
Media Contacts
Tammi Thomas, President, TEDCO, tthomas@tedcomd.com
Rachael Kalinyak, Associate Director, Marketing & Communications, TEDCO, rkalinyak@tedcomd.com